Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Clinical trial NCT02870244 · RECRUITING
Trial details
- NCT number
- NCT02870244
- Sponsor
- Loyola University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2028-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.